Steven R. Feldman

TL;DR: Promising new treatments for atopic dermatitis are reviewed and how their targets—IL-13, IL-31, OX40 (CD134), and the Janus kinase family of proteins—participate in the pathogenesis of AD is discussed.

TL;DR: The Task Force on Psoriasis during the COVID-19 pandemic as discussed by the authors included 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care to provide guidance for the treatment of patients with psoriatic disease on topics including how the disease and its treatments affect COVID19 risk, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 (including novel vaccination), and what they should do if they develop CO

TL;DR: Research has identified reinforcing properties associated with tanning and suggest a possible physiologic mechanism and addiction driving tanning behavior that may be linked to substance abuse.

TL;DR: Recent treatment guidelines are evaluated in terms of evaluation criteria, treatment recommendations, usability, accessibility, and applicability to nonspecialists and integrates them with clinical evidence to present a streamlined severity-based treatment model for the management of a majority of atopic dermatitis cases.

TL;DR: Oral griseofulvin is still the present treatment of choice for tinea capitis for the combined reasons of efficacy, safety, and cost, and a long track record of use.